ChemicalBook >> CAS DataBase List >>3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
- CAS No.
- 2174011-55-1
- Chemical Name:
- 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
- Synonyms
- Tofacitinib S,S Isomer;Tofacitib impurity TFB-C;Tofatinib Impurity C(Citrate);Tofacitinib Impurity 30 Citrate;Tofacitinib Impurity 58 Citrate;Tofacitinib Impurity 62 Citrate;Tofacitinib Impurity 53 Citrate;Tofacitinib isomer impurity(TFC3-T1);Tofacitinib -S,S-isomer(other isomer);3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl) amino)piperidin-1-yl)-3-oxopropanenitrile citrate
- CBNumber:
- CB14901803
- Molecular Formula:
- C22H28N6O8
- Molecular Weight:
- 504.5
- MDL Number:
- MFCD28398116
- MOL File:
- 2174011-55-1.mol
Last updated:2025-10-14 17:28:56
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501 |
3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile Preparation Products And Raw materials
Raw materials
Preparation Products
3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile Suppliers
Global( 32)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| sgtlifesciences pvt ltd | +8617013299288 | dj@sgtlifesciences.com | China | 12373 | 58 |
| ShenZhen H&D Pharmaceutical Technology Co., LTD | +8618627948422 | sale@hdimpurity.com | China | 3681 | 58 |
| Sinco Pharmachem (ShenZhen) R&D Co., Ltd. | +undefined18603013401 | jack.lin@sincopharmachem.com | China | 9996 | 58 |
| Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 | han_yajun@dctc.daicel.com | China | 7440 | 65 |
| Shandong Boluoda Biological Technology Co., Ltd. | 0531-68659041 | 2310993908@qq.com | China | 2917 | 58 |
| Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 | greensnown@163.com | China | 9906 | 50 |
| Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 | 3003392093@yongstandards.com | China | 9999 | 55 |
| Zhengzhou Kangshan Biological Co., Ltd. | +86-0371-55023472 +86-13663848272 | 2584787837@qq.com | China | 242 | 58 |
| Shenzhen Botel Biotechnology Co. Ltd. | 13316949107 13316968096 | 1979313431@qq.com | China | 9569 | 58 |
| Tianjin shijia biomedical technology co., LTD | 15022261580 15022261580; | tjshj1212@163.com | China | 2747 | 58 |
View Lastest Price from 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-03-12 | Tofacitinib Impurity C(Citrate)
2174011-55-1
|
US $0.00-0.00 / mg | 10mg | 0.98 | 10g | ShenZhen H&D Pharmaceutical Technology Co., LTD |
-

- Tofacitinib Impurity C(Citrate)
2174011-55-1
- US $0.00-0.00 / mg
- 0.98
- ShenZhen H&D Pharmaceutical Technology Co., LTD
2174011-55-1(3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile)Related Search:
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine
4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE
Ethanone, 2-methoxy-1-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity 85
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
4-Amino-2,6-dichloropyrimidine
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
2-Chloro-3,7-dihydro-4H-pyrrolo[2,3-d]pyriMidin-4-one
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-7-[(4-methylphenyl)sulfonyl]-N-[(3R,4R)-4-methyl-3-piperidinyl]-
1of4
Tofacitib impurity TFB-C
Tofacitinib -S,S-isomer(other isomer)
Tofacitinib S,S Isomer
Tofacitinib isomer impurity(TFC3-T1)
Tofatinib Impurity C(Citrate)
Tofacitinib Impurity 53 Citrate
Tofacitinib Impurity 62 Citrate
Tofacitinib Impurity 58 Citrate
Tofacitinib Impurity 30 Citrate
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl) amino)piperidin-1-yl)-3-oxopropanenitrile citrate
2174011-55-1





